AGT and cardiac hypertrophy: The use of CsA in animal models can effectively block or reduce cardiac hypertrophy caused by Ang II, β-AR and pressure load [94–96], but simply knocking out CN expression does not effectively improve cardiac hypertrophy [97], suggesting that CyPA may be a more important factor in promoting cardiac hypertrophy.